Revisiting the regulatory roles of the TGF-β family of cytokines

Autoimmunity Reviews

Volumn 15, Issue 9, 2016, Pages 917-922

  Fujio, Keshi ^a   Komai, Toshihiko ^a   Inoue, Mariko ^a   Morita, Kaoru ^a   Okamura, Tomohisa ^a   Yamamoto, Kauzhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

B cell; Integrin; Regulatory T cell; TGF beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; DNA BINDING; ENHANCER REGION; EXTRACELLULAR MATRIX; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; NONHUMAN; ORGANOGENESIS; PANCREAS ISLET BETA CELL; PLEIOTROPY; PROMOTER REGION; PROTEIN ENGINEERING; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; WOUND HEALING; ANIMAL; B LYMPHOCYTE; FIBROSIS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; FIBROSIS; HUMANS; IMMUNE TOLERANCE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 85002947698     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.07.007     Document Type: Review

References (64)

1. [1] Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K., Flavell, R.A., Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol, 24, 2006, 99.
2. [2] Kehrl, J.H., Wakefield, L.M., Roberts, A.B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med, 163, 1986, 1037.
3. [3] Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature, 359, 1992, 693.
4. [4] Rubtsov, Y.P., Rudensky, A.Y., TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol, 7, 2007, 443.
5. [5] Fujio, K., Okamura, T., Sumitomo, S., Yamamoto, K., Therapeutic potential of regulatory cytokines that target B cells. Int Immunol, 2015.
6. [6] Li, M.O., Flavell, R.A., TGF-beta: a master of all T cell trades. Cell, 134, 2008, 392.
7. [7] ten Dijke, P., Arthur, H.M., Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol, 8, 2007, 857.
8. [8] Mu, Y., Gudey, S.K., Landstrom, M., Non-Smad signaling pathways. Cell Tissue Res, 347, 2012, 11.
9. [9] Laverty, H.G., Wakefield, L.M., Occleston, N.L., O'Kane, S., Ferguson, M.W., TGF-beta3 and cancer: a review. Cytokine Growth Factor Rev, 20, 2009, 305.
10. [10] Brabletz, T., Pfeuffer, I., Schorr, E., Siebelt, F., Wirth, T., Serfling, E., Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol, 13, 1993, 1155.
11. [11] McKarns, S.C., Schwartz, R.H., Kaminski, N.E., Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J Immunol, 172, 2004, 4275.
12. [12] Wolfraim, L.A., Walz, T.M., James, Z., Fernandez, T., Letterio, J.J., p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness. J Immunol, 173, 2004, 3093.
13. [13] Gorelik, L., Flavell, R.A., Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity, 12, 2000, 171.
14. [14] Lucas, P.J., Kim, S.J., Melby, S.J., Gress, R.E., Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med, 191, 2000, 1187.
15. [15] Li, M.O., Sanjabi, S., Flavell, R.A., Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity, 25, 2006, 455.
16. [16] Marie, J.C., Liggitt, D., Rudensky, A.Y., Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity, 25, 2006, 441.
17. [17] Zhang, N., Bevan, M.J., TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol, 13, 2012, 667.
18. + regulatory T cells. Nat Immunol, 9, 2008, 632.
19. [19] Schlenner, S.M., Weigmann, B., Ruan, Q., Chen, Y., von Boehmer, H., Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med, 209, 2012, 1529.
20. [20] Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature, 500, 2013, 232.
21. [21] Tran, D.Q., TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol, 4, 2012, 29.
22. [22] Yan, J., Harvey, B.P., Gee, R.J., Shlomchik, M.J., Mamula, M.J., B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol, 177, 2006, 4481.
23. + T cell activation in mice. Proc Natl Acad Sci U S A, 104, 2007, 20878.
24. [24] Giles, J.R., Kashgarian, M., Koni, P.A., Shlomchik, M.J., B cell-specific MHC class II deletion reveals multiple nonredundant roles for B cell antigen presentation in murine lupus. J Immunol, 195, 2015, 2571.
25. [25] Warner, G.L., Ludlow, J.W., Nelson, D.A., Gaur, A., Scott, D.W., Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. Cell Growth Differ, 3, 1992, 175.
26. [26] Lomo, J., Blomhoff, H.K., Beiske, K., Stokke, T., Smeland, E.B., TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol, 154, 1995, 1634.
27. [27] Briskin, M., Kuwabara, M.D., Sigman, D.S., Wall, R., Induction of kappa transcription by interferon-gamma without activation of NF-kappa B. Science, 242, 1988, 1036.
28. [28] Kehrl, J.H., Thevenin, C., Rieckmann, P., Fauci, A.S., Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol, 146, 1991, 4016.
29. [29] Roes, J., Choi, B.K., Cazac, B.B., Redirection of B cell responsiveness by transforming growth factor beta receptor. Proc Natl Acad Sci U S A, 100, 2003, 7241.
30. [30] Letterio, J.J., Geiser, A.G., Kulkarni, A.B., Dang, H., Kong, L., Nakabayashi, T., et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest, 98, 1996, 2109.
31. [31] Cazac, B.B., Roes, J., TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity, 13, 2000, 443.
32. [32] Jelicic, K., Cimbro, R., Nawaz, F., Huang da, W., Zheng, X., Yang, J., et al. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-beta1 production and FcRL4 expression. Nat Immunol, 14, 2013, 1256.
33. [33] Yoon, J.H., Sudo, K., Kuroda, M., Kato, M., Lee, I.K., Han, J.S., et al. Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation. Nat Commun, 6, 2015, 7600.
34. [34] McGeachy, M.J., Cua, D.J., Th17 cell differentiation: the long and winding road. Immunity, 28, 2008, 445.
35. [35] Derynck, R., Lindquist, P.B., Lee, A., Wen, D., Tamm, J., Graycar, J.L., et al. A new type of transforming growth factor-beta, TGF-beta 3. EMBO J, 7, 1988, 3737.
36. [36] Proetzel, G., Pawlowski, S.A., Wiles, M.V., Yin, M., Boivin, G.P., Howles, P.N., et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet, 11, 1995, 409.
37. [37] Yang, L.T., Kaartinen, V., Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants. Dev Biol, 312, 2007, 384.
38. + Treg population via TGF-beta3. Eur J Immunol, 38, 2008, 2488.
39. [39] Lee, Y., Awasthi, A., Yosef, N., Quintana, F.J., Xiao, S., Peters, A., et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol, 13, 2012, 991.
40. [40] Chikuma, S., Suita, N., Okazaki, I.M., Shibayama, S., Honjo, T., TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol, 13, 2012, 596.
41. [41] Baixeras, E., Huard, B., Miossec, C., Jitsukawa, S., Martin, M., Hercend, T., et al. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med, 176, 1992, 327.
42. [42] Workman, C.J., Vignali, D.A., Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J Immunol, 174, 2005, 688.
43. + regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci U S A, 106, 2009, 13974.
44. [44] Awasthi, A., Carrier, Y., Peron, J.P., Bettelli, E., Kamanaka, M., Flavell, R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol, 8, 2007, 1380.
45. + T cells. Eur J Immunol, 43, 2013, 1063.
46. + T cells by inducing Blimp1. Nat Commun, 5, 2014, 3770.
47. [47] Zhu, B., Symonds, A.L., Martin, J.E., Kioussis, D., Wraith, D.C., Li, S., et al. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J Exp Med, 205, 2008, 2295.
48. [48] Myouzen, K., Kochi, Y., Shimane, K., Fujio, K., Okamura, T., Okada, Y., et al. Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus. Hum Mol Genet, 19, 2010, 2313.
49. + regulatory T cells control humoral immune responses. Nat Commun, 6, 2015, 6329.
50. [50] Munger, J.S., Huang, X., Kawakatsu, H., Griffiths, M.J., Dalton, S.L., Wu, J., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell, 96, 1999, 319.
51. [51] Travis, M.A., Sheppard, D., TGF-beta activation and function in immunity. Annu Rev Immunol, 32, 2014, 51.
52. [52] Aluwihare, P., Mu, Z., Zhao, Z., Yu, D., Weinreb, P.H., Horan, G.S., et al. Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice. J Cell Sci, 122, 2009, 227.
53. [53] Gerber, E.E., Gallo, E.M., Fontana, S.C., Davis, E.C., Wigley, F.M., Huso, D.L., et al. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma. Nature, 503, 2013, 126.
54. [54] Taya, Y., O'Kane, S., Ferguson, M.W., Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development, 126, 1999, 3869.
55. [55] Hall, B.E., Wankhade, U.D., Konkel, J.E., Cherukuri, K., Nagineni, C.N., Flanders, K.C., et al. Transforming growth factor-beta3 (TGF-beta3) knock-in ameliorates inflammation due to TGF-beta1 deficiency while promoting glucose tolerance. J Biol Chem, 288, 2013, 32074.
56. [56] Ferguson, M.W., O'Kane, S., Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci, 359, 2004, 839.
57. [57] Whitby, D.J., Ferguson, M.W., The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development, 112, 1991, 651.
58. [58] Shah, M., Foreman, D.M., Ferguson, M.W., Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci, 108(Pt 3), 1995, 985.
59. [59] Ferguson, M.W., Duncan, J., Bond, J., Bush, J., Durani, P., So, K., et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet, 373, 2009, 1264.
60. [60] Lichtman, M.K., Otero-Vinas, M., Falanga, V., Transforming growth factors beta (TGF-beta) isoforms in wound healing and fibrosis. Wound Repair Regen, 2015.
61. [61] Ask, K., Bonniaud, P., Maass, K., Eickelberg, O., Margetts, P.J., Warburton, D., et al. Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. Int J Biochem Cell Biol, 40, 2008, 484.
62. [62] Hemmerle, T., Doll, F., Neri, D., Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis. Proc Natl Acad Sci U S A, 111, 2014, 12008.
63. [63] Doll, F., Schwager, K., Hemmerle, T., Neri, D., Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse. Arthritis Res Ther, 15, 2013, R138.
64. [64] Monteleone, G., Neurath, M.F., Ardizzone, S., Di Sabatino, A., Fantini, M.C., Castiglione, F., et al. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N Engl J Med, 372, 2015, 1104.